0001730052-23-000001.txt : 20230613 0001730052-23-000001.hdr.sgml : 20230613 20230613202922 ACCESSION NUMBER: 0001730052-23-000001 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vanda Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001347178 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030491827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-34186 FILM NUMBER: 231012733 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 BUSINESS PHONE: 202-734-3400 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Williams Timothy CENTRAL INDEX KEY: 0001748392 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O VANDA PHARMACEUTICALS INC. STREET 2: 2200 PENNSYLVANIA AVENUE NW, SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 144 1 primary_doc.xml 144 0001748392 XXXXXXXX LIVE 0001347178 Vanda Pharmaceuticals Inc. 001-34186 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON CA 20037 202-734-3400 Williams Timothy Officer Common Stock Merrill Lynch

1152 15th St., NW Suite 6000 Washington DC 20005

14600 96360.00 57444139 06/13/2023 NASDAQ Common Stock 03/01/2023 Vesting/Settlement of Restricted Stock Units Issuer N 14600 03/01/2023 Compensation Y 06/13/2023 /s/ Timothy Williams